Etanercept With IVIg for Acute Kawasaki Disease: A Randomized Controlled Trial
Michael A. Portman(Seattle Children's Hospital), Nagib Dahdah(Centre Hospitalier Universitaire Sainte-Justine), April Slee(University College London), Aaron Olson(Seattle Pacific University), Nadine Choueiter(Mount Sinai Hospital), Sujatha Buddhe(Seattle Children's Hospital), Brian D. Soriano(Seattle Children's Hospital), Carolyn A. Altman
Cited by 82
Related Papers
Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease
|Nature Genetics|2011|355
New Equations and a Critical Appraisal of Coronary Artery Z Scores in Healthy Children
|Journal of the American Society of Echocardiography|2010|309
Assessing Cardiac Metabolism
|Circulation Research|2016|284
All-Cause Mortality and Cardiovascular Outcomes With Prophylactic Steroid Therapy in Duchenne Muscular Dystrophy
|Journal of the American College of Cardiology|2013|220
Deep feature learning for automatic tissue classification of coronary artery using optical coherence tomography
|Biomedical Optics Express|2017|132